Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated to proteinaceous toxin or fragment thereof
Patent
1995-11-22
1998-07-14
Budens, Robert D.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated to proteinaceous toxin or fragment thereof
4241381, 4241551, 4241741, 435 723, 435 7021, 4351722, 435344, 5303888, 5303897, A61K 39395, G01N 33574, C12N 520, C07K 1630
Patent
active
057800332
ABSTRACT:
A method of inhibiting the growth of a tumor cell in a mammal by administering to the mammal an autoantibody, e.g, an antinuclear autoantibody from an aged mammal, that binds to either one or both of a surface of a tumor cell and a protein released from a dead tumor cell. Also disclosed are natural and monoclonal antinuclear autoantibodies from aged mammals and a hybridoma cell line producing a monoclonal antinuclear autoantibody.
REFERENCES:
Ben-Yehuda et al., "Immune Senescence:Mechanisms and Clinical Implications", Cancer Investigation,10(6):525 -531 (1992).
Chen et al., "A Comparative Autoradiographic Study Demonstrationg Differential Intratumor Localization of Monoclonal Antibodies to Cell Surface (Lym-1) and Intracellular . . . ", J. Nuc. Med., 31:1059-1066 (1990).
Jacob et al., "A monoclonal anti-double-stranded DNA autoantibody binds to a 94-kDa cell-surface protein on various cell types via nucleosomes or a DNA-histone complex", Proc. Natl. Acad. Sci. USA, 86:4669-4673 (1989).
O'Sullivan et al., "Long-Term Anti-CD4 Treatment of MRL/Ipr Mice Ameliorates Immunopathology and Lymphoproliferation but Fails to Suppress . . .", Clin. Immunology and Immunopathology, 61:421-435 (1991).
Prabhakar et al., "Cell Surface Expression of the 70-kD Component of Ku, a DNA-binding Nuclear Autoantigen", J. Clin. Invest. Inc.,86:1301-1305 (1990).
Raz et al., "Cross-reactions of anti-DNA autoantibodies with Cell Surface Proteins", Eur. J. Immunol. 23:383-390 (1993).
Rekvig et al., "Intrinsic Cell Membrane Antigens Recognized by Antichromatin Autoantibodies", Scan. J. Immunol., 29:7-13 (1989).
Ricotti et al., "Autoantibodies to purified nuclear proteins related to DNA metabolism during ageing and in SLE patients", Immunology, 61:375-381 (1987).
Sakharova et al., "Ontogenetic Changes in Spectrum of Specificities of Brain Reactive Monoclonal Natural Antibodies", Zh. Obshch. Biol.,
Walker et al., "Accelerated Appearance of Neoplasms in Female NZB/NZW Mice Treated with High-Dose Cyclophosphamide", Arthritis and Rheumatism,22:1338-1343 (1979).
Walker et al., "Suppressed heterogeneous antinuclear antibody response in lymphoma-bearing NZB/NZW mice," Clin. exp. Immunol., 24:210-217 (1976).
Banks et al. Characterization of cross reactive .varies.-DNA autoantibodies in murine Lupus Immunol. Invest. 22:229, 1993.
Goding Mabs: Principles & Practice Production & Application of MAbs in Cell Biology, Biochem., +Immunol. Academic Press, 1986.
Winter et al. Abs against autologous tumor cell proteins in Patents with SCLC: Association with survival JNCI 85:2012, 1993.
Langdon et al. Characterization +Properties of a SCLC line Xenograft WX322 with Marked Sensitivity to .varies.-IFN. Br. J. cancer 63:909, 1991.
Cronstein et al. The Adhesion Molecules of Inflammation Arthr. +Rheum. 36:147, 1993.
Osband et al. Problems in the Investigational Study + Clinical Use of Cancer Immunotherapy Immunol. Today 11:193, 1990.
Jain Barriers to Drug Delivery in Solid Tumors Sci Am 271:58, 1994.
Chatterjee et al. "Idiotypic Antibody Immunotherapy of Cancer", Cancer Immunother, 38:75-82, (1994).
Cronstein et al., "The Adhesion Molecules of Inflammation", Arthritis and Rheumatism, 36:147-157, (1993).
Goding, "Monoclonal Antibodies: Principles and Practice", Production and Application of Monoclonal Antibodies in Cell Biology, Biochemistry and Immunology, Academic Press, 2nd Edition, pp. 79-113, (1986).
Jain, Barriers to Drug Delivery in Solid Tumors, Scientific American, 271(1):58-65, (1994).
Langdon et al., Characterisation and properties of a small lung cancer cell line and xenograft WX322 with marked sensitivity to alpha-interferon, Br. J. Cancer, 63:909-915, (1991).
Osband et al., "Problems in the investigational study and clinical use of cancer immunotherapy", Immunology Today, 11:193-195, (1990).
Raz et al., "Cross-reactions of anti-DNA autoantibodies with Cell Surface Proteins", Eur. J. Immunol. Today, 11:193-195 (1990).
Winter et al., Antibodies Against Autoglous Tumor Cell Proteins in Patients With Small-Cell Lung Cancer: Association With Improved Survival, J. Nat. Cancer Inst., 85:2012-2018, (1993).
Ricotti et al., "Autoantibodies to purified nuclear proteins related to DNA metabolism during ageing and in SLE patients", Immunology, 61:375-381 (1987).
Iakoubov Leonid Z.
Torchilin Vladimir P.
LandOfFree
Use of autoantibodies for tumor therapy and prophylaxis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of autoantibodies for tumor therapy and prophylaxis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of autoantibodies for tumor therapy and prophylaxis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1879250